Results
|
50081.
|
|
|
50082.
|
|
|
50083.
|
|
|
50084.
|
|
|
50085.
|
|
|
50086.
|
|
|
50087.
|
|
|
50088.
|
|
|
50089.
|
|
|
50090.
|
|
|
50091.
|
|
|
50092.
|
|
|
50093.
|
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma. [electronic resource] by
- Cocconi, G
- Carlini, P
- Gamboni, A
- Gasperoni, S
- Rodinò, C
- Zironi, S
- Bisagni, G
- Porrozzi, S
- Cognetti, F
- Di Costanzo, F
- Canaletti, R
- Ruggeri, E M
- Camisa, R
- Pucci, F
Producer: 20031017
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 14
Availability: No items available.
|
|
50094.
|
|
|
50095.
|
|
|
50096.
|
|
|
50097.
|
|
|
50098.
|
|
|
50099.
|
|
|
50100.
|
|